10 Stock Market News for "PRSP"

Obalon Appoints Bob MacDonald as Chief Retail Officer

SAN DIEGO, June 10, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces the appointment of Bob MacDonald to the newly created position of Chief Retail Officer. In this role, Mr. MacDonald will be ... »

7 Stocks To Watch For June 7, 2019

Some of the stocks that may grab investor focus today are: Beyond Meat Inc (NASDAQ: BYND) reported stronger-than-expected results for its first quarter on Thursday. Beyond Meat shares climbed 18.1 percent to $117.49 in the after-hours trading session. Vail Resorts, Inc. (NYSE: MTN) reported upbeat earnings for its third quarter on Thursday. Vail Resorts shares gained 5.7 percent to $230.50 in the ... »

Earnings Scheduled For June 6, 2019

Companies Reporting Before The Bell Science Applications International Corporation (NYSE: SAIC) is expected to report quarterly earnings at $1.16 per share on revenue of $1.62 billion. The J. M. Smucker Company (NYSE: SJM) is estimated to report quarterly earnings at $1.95 per share on revenue of $1.93 billion. Ciena Corporation (NYSE: CIEN) is expected to report quarterly earnings at $0.41 per sh... »

Perspecta Awarded $75 Million Program to Support the Continued Reform and Modernization for the National Background Investigation Service

CHANTILLY, Va., May 28, 2019 /PRNewswire/ — Perspecta Inc. (NYSE: PRSP), a leading U.S. government services provider, announced today that it has been awarded an Other Transaction Agreement  (OTA) from the Defense Security Service (DSS) and Defense Information Systems Agency (DISA), to support the continued reform and modernization strategy for the National Background Investigation Serv... »

Abdominal Aortic Aneurysm Repair Device Market to Reach USD 3.62 Billion by 2026 | Reports And Data

Rising prevalence of Abdominal Aortic Aneurysm due to rise in geriatric population and unhealthy living habits, new product launches, increasing strategic developments such as mergers and acquisitions, marketing techniques, favorable research funding scenario, adequate insurance coverage and reimbursements are key factors contributing to high CAGR of Abdominal Aortic Aneurysm Repair Device Market ... »

Trivedi Global, Inc. Announces Research by Dahryn Trivedi on the Impact of the Trivedi Effect® on Hair Growth

Las Vegas, Nevada, USA, May 21, 2019 (GLOBE NEWSWIRE) — Dahryn Trivedi, an evidence-based healer, today released research results from preclinical research on the impact of biofield energy healing treated nutraceutical (herbal) formulation for hair growth and skin health. The preclinical research shows: Hair growth increased by 60% Melanogenesis increased by 60% Overall, this biofield energy... »

Perspecta Increases Its Cash Dividend by 20 Percent and Appoints Glenn A. Eisenberg to its Board of Directors

CHANTILLY, Va., May 21, 2019 /PRNewswire/ — Perspecta Inc. (NYSE:PRSP), a leading U.S. government services provider, announced today that its board of directors approved an increase in the company’s regular cash dividend approach for fiscal year 2020, declaring a cash dividend of $0.06 per share for the quarter ended March 31, 2019, a 20 percent increase over the previous quarterl... »

Perspecta recognized as Microsoft Gold Partner for Cloud Migration

CHANTILLY, Va., May 16, 2019 /PRNewswire/ — Perspecta Inc. (NYSE:PRSP), a leading U.S. government services provider, announced today that it has been recognized as a Microsoft Gold Partner and a Microsoft Cloud Solution Provider (CSP).  The Microsoft gold competency represents the highest level of expertise with Microsoft solutions and further validates Perspecta’s place as a lead... »

Forty Seven, Inc. to Present Updated Data from Ongoing Phase 1b/2 Clinical Trial of 5F9 in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma at 24th Congress of the European Hematology Association

MENLO PARK, Calif., May 16, 2019 (GLOBE NEWSWIRE) — Forty Seven, Inc., a clinical-stage immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced that updated data from its ongoing Phase 1b/2 clinical trial evaluating 5F9 in combination with rituximab for the treatment of relapsed/refractory non-Hodgkin’s lymphoma (r/r NHL), ... »

Perspecta to Provide Cyber Electronic Warfare Support on $982 Million United States Army Program

CHANTILLY, Va., May 8, 2019 /PRNewswire/ — Perspecta Inc. (NYSE:PRSP), a leading U.S. government services provider, announced today that it has been selected to provide cyber electronic warfare support to the U.S. Army Program Executive Office for Intelligence, Electronic Warfare, and Sensors (PEO IEW&S) on the R4 program. R4 is a 10-year, indefinite delivery, indefinite quantity, m... »